Effectiveness of Caplacizumab vs Standard of Care in Immune Thrombotic Thrombocytopenic Purpura
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Real-world effectiveness of caplacizumab vs standard of care in immune thrombotic thrombocytopenic purpura
Blood Adv 2022 Aug 05;[EPub Ahead of Print], MC Pascual Izquierdo, ME Mingot-Castellano, AE Kerguelen Fuentes, J García-Arroba Peinado, J Cid, M Jiménez, D Valcarcel, I Gomez-Segui, J de la Rubia, P Martin, R Goterris, LM Hernández-Mateo, I Tallón Ruiz, S Varea, M Fernández-Docampp, N García-Muñoz, M Vara, M Fernández Zarzoso, F García-Candel, ML Paciello, I García-García, S Zalba, V Campuzano Saavedra, JMM Garcia-Gala, J Vidan, G Moreno, JL Lopez Lorenzo, E González Arias, C Freiría, M Solé, LF Ávila Idrovo, JC Hernández Castellet, N Cruz, E Lavilla, A Pérez-Montaña, JA Atucha, ME Moreno Beltrán, JR Romero Macías, R Salinas Argente, J Del Rio-GarmaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.